Duality Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-90,881	Closed	-$1.71M	–	499
2023 Q1	$1.71M	Buy	90,881 +6,216	+7%	+$118K	0.19%	191
2022 Q4	$1.35M	Sell	84,665 -27,574	-25%	-$431K	0.15%	238
2022 Q3	$1.84M	Sell	112,239 -100,855	-47%	-$1.63M	0.2%	199
2022 Q2	$3M	Buy	213,094 +190,976	+863%	+$3.56M	0.3%	102
2022 Q1	$536K	Buy	+22,118	New	+$535K	0.06%	458
2021 Q4	–	Sell	-132,205	Closed	-$2.2M	–	468
2021 Q3	$2.2M	Buy	132,205 +121,596	+1,146%	+$2.34M	0.17%	233
2021 Q2	$259K	Sell	10,609 -5,732	-35%	-$129K	0.02%	491
2021 Q1	$422K	Sell	16,341 -12,297	-43%	-$541K	0.04%	462
2020 Q4	$1.53M	Buy	+28,638	New	+$1.42M	0.11%	267